These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22438805)

  • 1. E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.
    Saha A; Lu J; Morizur L; Upadhyay SK; Aj MP; Robertson ES
    PLoS Pathog; 2012; 8(3):e1002573. PubMed ID: 22438805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.
    Cai Q; Guo Y; Xiao B; Banerjee S; Saha A; Lu J; Glisovic T; Robertson ES
    PLoS Pathog; 2011 Dec; 7(12):e1002418. PubMed ID: 22174681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBV Nuclear Antigen 3C Mediates Regulation of E2F6 to Inhibit E2F1 Transcription and Promote Cell Proliferation.
    Pei Y; Banerjee S; Sun Z; Jha HC; Saha A; Robertson ES
    PLoS Pathog; 2016 Aug; 12(8):e1005844. PubMed ID: 27548379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.
    Saha A; Bamidele A; Murakami M; Robertson ES
    J Virol; 2011 Mar; 85(5):2079-88. PubMed ID: 21177815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.
    Saha A; Halder S; Upadhyay SK; Lu J; Kumar P; Murakami M; Cai Q; Robertson ES
    PLoS Pathog; 2011 Feb; 7(2):e1001275. PubMed ID: 21347341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The F-box E3 ligase protein FBXO11 regulates EBNA3C-associated degradation of BCL6.
    Sun K; Bose D; Singh RK; Pei Y; Robertson ES
    J Virol; 2024 Jul; 98(7):e0054824. PubMed ID: 38864622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation.
    Shukla SK; Jha HC; El-Naccache DW; Robertson ES
    Oncotarget; 2016 Apr; 7(14):18116-34. PubMed ID: 26908453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.
    Jha HC; A J MP; Saha A; Banerjee S; Lu J; Robertson ES
    J Virol; 2014 Apr; 88(7):3776-88. PubMed ID: 24429368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation.
    Zhang S; Pei Y; Lang F; Sun K; Singh RK; Lamplugh ZL; Saha A; Robertson ES
    PLoS Pathog; 2019 Jan; 15(1):e1007514. PubMed ID: 30615685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.
    Yi F; Saha A; Murakami M; Kumar P; Knight JS; Cai Q; Choudhuri T; Robertson ES
    Virology; 2009 Jun; 388(2):236-47. PubMed ID: 19394062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.
    Banerjee S; Lu J; Cai Q; Saha A; Jha HC; Dzeng RK; Robertson ES
    PLoS Pathog; 2013; 9(5):e1003314. PubMed ID: 23658517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.
    Saha A; Murakami M; Kumar P; Bajaj B; Sims K; Robertson ES
    J Virol; 2009 May; 83(9):4652-69. PubMed ID: 19244339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus nuclear antigen 3C interact with p73: Interplay between a viral oncoprotein and cellular tumor suppressor.
    Sahu SK; Mohanty S; Kumar A; Kundu CN; Verma SC; Choudhuri T
    Virology; 2014 Jan; 448():333-43. PubMed ID: 24314664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferation.
    Banerjee S; Lu J; Cai Q; Sun Z; Jha HC; Robertson ES
    PLoS Pathog; 2014 Aug; 10(8):e1004304. PubMed ID: 25121590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.
    Skalska L; White RE; Franz M; Ruhmann M; Allday MJ
    PLoS Pathog; 2010 Jun; 6(6):e1000951. PubMed ID: 20548956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr Virus Nuclear Antigen 3C Facilitates Cell Proliferation by Regulating Cyclin D2.
    Pei Y; Singh RK; Shukla SK; Lang F; Zhang S; Robertson ES
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29997218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.
    Skalska L; White RE; Parker GA; Turro E; Sinclair AJ; Paschos K; Allday MJ
    PLoS Pathog; 2013 Feb; 9(2):e1003187. PubMed ID: 23436997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus nuclear antigen 3C (EBNA3C) interacts with the metabolism sensing C-terminal binding protein (CtBP) repressor to upregulate host genes.
    Ohashi M; Hayes M; McChesney K; Johannsen E
    PLoS Pathog; 2021 Mar; 17(3):e1009419. PubMed ID: 33720992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Bristol JA; Ma S; Ranheim EA; Gumperz J; Johannsen EC; Kenney SC
    PLoS Pathog; 2018 Aug; 14(8):e1007221. PubMed ID: 30125329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the
    Bazot Q; Paschos K; Allday MJ
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29367247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.